Definition/General
Introduction:
Esophageal stricture represents abnormal narrowing of the esophageal lumen due to fibrotic tissue formation
Most commonly results from chronic gastroesophageal reflux disease (GERD)
Peptic strictures account for 70-80% of benign esophageal strictures
Leads to progressive dysphagia and impaired esophageal function
Distinguished from malignant strictures by absence of dysplasia or carcinoma.
Origin:
Results from chronic inflammation and repeated mucosal injury
Acid reflux causes recurring ulceration and healing
Fibroblast activation leads to excessive collagen deposition
Smooth muscle hypertrophy and fibrosis develop
Progressive scarring results in luminal narrowing
Healing response to chronic mucosal damage.
Classification:
Peptic strictures (most common, from GERD)
Caustic strictures (chemical injury)
Radiation strictures (post-radiation therapy)
Post-surgical strictures (anastomotic)
Infectious strictures (post-esophagitis)
Congenital strictures (rare)
Simple vs complex strictures based on morphology.
Epidemiology:
Develops in 10-20% of patients with chronic GERD
Peak incidence in 5th-7th decades
Male predominance (2:1 ratio)
Associated with Barrett's esophagus in 40-60% cases
More common in Caucasian population
H
pylori negative patients at higher risk.
Clinical Features
Presentation:
Progressive dysphagia to solids initially, then liquids
Food impaction episodes
Regurgitation of undigested food
Weight loss due to decreased oral intake
Chest pain or discomfort
Heartburn and reflux symptoms
Aspiration pneumonia risk
Malnutrition in severe cases.
Symptoms:
Gradual onset dysphagia over months to years
Solid food initially affected
Intermittent symptoms early, becoming constant
Compensatory behaviors (smaller bites, liquids with meals)
Nocturnal regurgitation
Chronic cough from aspiration
Iron deficiency anemia.
Risk Factors:
Chronic GERD (most important)
Barrett's esophagus
Hiatal hernia
Previous caustic ingestion
Radiation therapy to chest
Esophageal surgery
Prolonged nasogastric intubation
Scleroderma and connective tissue disorders
Male gender and advanced age.
Screening:
Barium swallow shows luminal narrowing and upstream dilatation
Upper endoscopy for direct visualization and biopsy
Endoscopic ultrasound assesses wall thickness
pH monitoring confirms acid reflux
Manometry evaluates esophageal motility
CT scan excludes malignancy.
Master Stricture Pathology with RxDx
Access 100+ pathology videos and expert guidance with the RxDx app
Gross Description
Appearance:
Smooth, concentric narrowing of esophageal lumen
Fibrotic, whitish appearance of the strictured area
Upstream dilatation of esophagus proximal to stricture
Thickened esophageal wall
Loss of normal mucosal folds
Smooth, regular margins (unlike malignant strictures).
Characteristics:
Peptic strictures: smooth, tapered narrowing in distal esophagus
Short segment involvement (1-4 cm)
Concentric narrowing pattern
Associated hiatal hernia common
Barrett's mucosa may be present
Inflammatory changes in surrounding tissue.
Size Location:
Most common in distal esophagus (2-5 cm above GEJ)
Length varies from 0.5-10 cm
Short strictures (<2 cm) more common
GEJ involvement frequent
Mid-esophageal location in caustic or radiation strictures
Multiple strictures possible.
Multifocality:
Single stricture most common pattern
Multiple strictures in 10-20% cases
Skip areas of normal mucosa
Associated Barrett's esophagus proximally
Concurrent peptic ulcer disease in some patients
Gastric involvement possible with severe GERD.
Microscopic Description
Histological Features:
Chronic inflammation in lamina propria and submucosa
Fibrosis with increased collagen deposition
Smooth muscle hypertrophy and disorganization
Submucosal gland hyperplasia
Vascular changes (congestion, sclerosis)
Surface ulceration may be present
Regenerative epithelial changes.
Cellular Characteristics:
Fibroblasts and myofibroblasts proliferation
Chronic inflammatory cells (lymphocytes, plasma cells)
Smooth muscle cell hypertrophy
Endothelial proliferation
Basal cell hyperplasia in squamous epithelium
Regenerating epithelium with increased mitotic activity.
Architectural Patterns:
Dense fibrous tissue replacing normal architecture
Thickened muscularis propria
Disorganized smooth muscle bundles
Submucosal fibrosis and gland entrapment
Vascular sclerosis
Loss of normal tissue layers in severe cases
Granulation tissue in active inflammation.
Grading Criteria:
Mild stricture: minimal fibrosis, preserved muscle layers
Moderate stricture: significant fibrosis, muscle disorganization
Severe stricture: dense fibrosis, complete architectural distortion
Grading based on degree of fibrosis and muscle involvement.
Immunohistochemistry
Positive Markers:
Smooth muscle actin highlights smooth muscle hypertrophy and myofibroblasts
Desmin shows smooth muscle cells
Collagen stains (Masson trichrome) demonstrate fibrosis
CD68 highlights macrophages
Ki-67 shows proliferative activity
Cytokeratins highlight epithelium.
Negative Markers:
Malignancy markers negative (excludes carcinoma)
Dysplasia markers negative in benign stricture
Infectious agents typically absent
Neuroendocrine markers negative
Melanoma markers negative.
Diagnostic Utility:
Smooth muscle markers assess muscle layer changes
Fibrosis stains quantify collagen deposition
Epithelial markers exclude dysplasia
Inflammatory markers assess activity
Proliferation markers indicate healing potential.
Molecular Subtypes:
TGF-β pathway activation in fibrosis development
PDGF signaling in smooth muscle proliferation
Inflammatory cytokine expression patterns
Matrix metalloproteinase activity
Acid-responsive gene expression signatures.
Molecular/Genetic
Genetic Mutations:
TGF-β pathway genes (TGFBR1, SMAD proteins)
Collagen synthesis genes (COL1A1, COL3A1)
Matrix remodeling genes (MMPs, TIMPs)
Inflammatory response genes (IL-1β, TNF-α)
Wound healing genes (PDGF, FGF)
p53 mutations rare in benign strictures.
Molecular Markers:
Growth factor expression (TGF-β, PDGF, CTGF)
Inflammatory cytokines (IL-6, IL-8)
Matrix proteins (collagen I, III, fibronectin)
Metalloproteinases and inhibitors
Oxidative stress markers
Apoptosis markers in epithelium.
Prognostic Significance:
Degree of fibrosis predicts response to dilation
Inflammatory activity indicates ongoing damage
Barrett's esophagus increases dysplasia risk
Length of stricture affects treatment success
Recurrence rate higher with severe fibrosis.
Therapeutic Targets:
Proton pump inhibitors for acid suppression
Endoscopic dilation (balloon or bougie)
Intralesional steroids to reduce fibrosis
Anti-fibrotic agents under investigation
Fundoplication surgery for refractory cases
Esophageal replacement for severe cases.
Differential Diagnosis
Similar Entities:
Malignant stricture (adenocarcinoma, squamous carcinoma)
Eosinophilic esophagitis
Achalasia
Esophageal rings and webs
Extrinsic compression (mediastinal masses)
Motility disorders
Inflammatory strictures (Crohn disease).
Distinguishing Features:
Benign stricture: smooth, tapered appearance
Benign: no dysplasia or malignancy on biopsy
Malignant: irregular, nodular appearance
Malignant: dysplasia or carcinoma present
EoE: eosinophils >15/HPF
Achalasia: failure of LES relaxation
Rings: thin, shelf-like appearance.
Diagnostic Challenges:
Distinguishing benign from malignant stricture
Multiple biopsies may be needed
Sampling error in dysplasia detection
Inflammatory atypia mimicking dysplasia
Coexistent Barrett's esophagus complicating assessment.
Rare Variants:
Congenital esophageal stricture
Medication-induced stricture (NSAIDs, bisphosphonates)
Eosinophilic esophagitis stricture
Post-infectious stricture
Autoimmune stricture (pemphigoid)
Vascular ring causing extrinsic compression.
Sample Pathology Report
Template Format
Sample Pathology Report
Complete Report: This is an example of how the final pathology report should be structured for this condition.
Specimen Information
Esophageal biopsies from strictured area at [location] with [endoscopic findings]
Clinical History
Progressive dysphagia with [GERD history/other risk factors]
Stricture Characteristics
Location: [proximal/distal]. Length: [X] cm. Appearance: [smooth/irregular]
Microscopic Findings
Shows [degree] of fibrosis with [chronic inflammation] and [smooth muscle changes]
Fibrosis Assessment
Fibrosis: [mild/moderate/severe]. Distribution: [submucosal/transmural]
Dysplasia Evaluation
No evidence of dysplasia or malignancy identified
Associated Findings
Barrett esophagus: [present/absent]. Active inflammation: [present/absent]
Prognostic Assessment
Benign stricture with [good/guarded] prognosis for endoscopic treatment
Recommendations
Acid suppression therapy. Endoscopic dilation as clinically indicated
Final Diagnosis
Benign esophageal stricture, [peptic/other type], with [degree] fibrosis